GRAIL Reports Q3 2026 Results with Increased Test Volumes Amidst Margin Compression
GRAIL, Inc. (GRAL) reported third-quarter 2026 revenue of $37.5 million, a 4% year-over-year increase, driven primarily by a 14% rise in screening revenue. While test volumes grew significantly by 24% to over 56,000 tests, the company faced margin pressure. Adjusted gross margin fell to 42% from 55% in the prior year, impacted by lower average selling prices (ASP) following a September 2026 price promotion and changes in sample mix. The company reported a net loss of $103.6 million, an increase of 16% compared to Q3 2025. Despite these losses, GRAIL maintains a strong liquidity position with $788.7 million in cash and marketable securities, providing a projected runway into 2029. Management updated its full-year 2026 revenue guidance to 17%-21% growth to account for the impact of promotional pricing strategies.
Topics: Financial Guidance Net Loss Revenue Growth Test Volume